Enterococcus: Difference between revisions

From IDWiki
Enterococcus
No edit summary
()
Line 1: Line 1:


== Background ==
==Background==


=== Microbiology ===
===Microbiology===
* Facultative anaerobic, non-spore-forming, [[Hemolysis pattern::α-hemolytic|alpha-]] or [[Hemolysis pattern::γ-hemolytic|gamma-hemolytic]], [[Catalase test::catalase-negative]], [[Stain::Gram-positive]] [[Cellular shape::cocci]]
* Grows on bile esculin agar
* Most are Lancefield group D
* Commensal gut flora
* Increasing antibiotic resistance


*Facultative anaerobic, non-spore-forming, [[Hemolysis pattern::α-hemolytic|alpha-]] or [[Hemolysis pattern::γ-hemolytic|gamma-hemolytic]], [[Catalase test::catalase-negative]], [[Stain::Gram-positive]] [[Cellular shape::cocci]]
=== Species ===
*Grows on bile esculin agar
* ''E. faecalis''
*[[PYR test|PYR]] positive
** More common (90-95%)
*Most are Lancefield group D
** More commonly genitourinary source
*Commensal gut flora
** More susceptible to antibiotics
*Increasing antibiotic resistance
* ''E. faecium''
** Less common (5-10%)
** More commonly gastrointestinal source
** Less susceptible to antibiotics
** Most common VRE
* ''E. gallinarum''
* ''E. casseliflavus''


=== Vacomycin Resistance ===
===Species===
* Vancomycin binds to d-Ala-d-Ala pentapeptids, interfering with cell wall synthesis
* '''VanA''': most common. Mutation to d-Ala-d-Lac, leading to high resistance to glycopeptides.
* '''VanB''': more common in ''E. faecium'' in Australia
* '''VanC''': chromosomal resistance on ''E. gallinarum'' and ''E. casseliflavus''


*''E. faecalis''
== Management ==
**More common (90-95%)
=== VRE ===
**More commonly genitourinary source
* [[Is treated by::Daptomycin]], [[Is treated by::doxycycline]], [[Is treated by::linezolid]], [[Is treated by::tedizolid]], [[Is treated by::oritavancin]], [[Is treated by::quinupristin-dalfopristin]] (for ''E. faecium'')
**More susceptible to antibiotics
*''E. faecium''
**Less common (5-10%)
**More commonly gastrointestinal source
**Less susceptible to antibiotics
**Most common VRE
*''E. gallinarum''
*''E. casseliflavus''

===Vacomycin Resistance===

*Vancomycin binds to d-Ala-d-Ala pentapeptids, interfering with cell wall synthesis
*'''VanA''': most common. Mutation to d-Ala-d-Lac, leading to high resistance to glycopeptides.
*'''VanB''': more common in ''E. faecium'' in Australia
*'''VanC''': chromosomal resistance on ''E. gallinarum'' and ''E. casseliflavus''

==Management==
===VRE===

*[[Is treated by::Daptomycin]], [[Is treated by::doxycycline]], [[Is treated by::linezolid]], [[Is treated by::tedizolid]], [[Is treated by::oritavancin]], [[Is treated by::quinupristin-dalfopristin]] (for ''E. faecium'')


{{DISPLAYTITLE:''Enterococcus'' species}}
{{DISPLAYTITLE:''Enterococcus'' species}}

Revision as of 13:17, 17 August 2020

Background

Microbiology

  • Facultative anaerobic, non-spore-forming, alpha- or gamma-hemolytic, catalase-negative, Gram-positive cocci"cocci" is not in the list (coccus, bacillus, coccobacillus, diplococcus, spirochete, curved, pleomorphic, yeast, mold) of allowed values for the "Shape" property.
  • Grows on bile esculin agar
  • PYR positive
  • Most are Lancefield group D
  • Commensal gut flora
  • Increasing antibiotic resistance

Species

  • E. faecalis
    • More common (90-95%)
    • More commonly genitourinary source
    • More susceptible to antibiotics
  • E. faecium
    • Less common (5-10%)
    • More commonly gastrointestinal source
    • Less susceptible to antibiotics
    • Most common VRE
  • E. gallinarum
  • E. casseliflavus

Vacomycin Resistance

  • Vancomycin binds to d-Ala-d-Ala pentapeptids, interfering with cell wall synthesis
  • VanA: most common. Mutation to d-Ala-d-Lac, leading to high resistance to glycopeptides.
  • VanB: more common in E. faecium in Australia
  • VanC: chromosomal resistance on E. gallinarum and E. casseliflavus

Management

VRE

References

  1. ^  James H. Jorgensen, Sharon A. Crawford, Cynthia C. Kelly, Jan E. Patterson. In VitroActivity of Daptomycin against Vancomycin-Resistant Enterococci ofVarious Van Types and Comparison of Susceptibility TestingMethods. Antimicrobial Agents and Chemotherapy. 2003;47(12):3760-3763. doi:10.1128/aac.47.12.3760-3763.2003.